{"id":810268,"date":"2025-02-06T17:21:30","date_gmt":"2025-02-06T22:21:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"},"modified":"2025-02-06T17:21:30","modified_gmt":"2025-02-06T22:21:30","slug":"crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","title":{"rendered":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Feb.  06, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QNYpDJ-5z26hYVjHN41zTvctIswIJ58agvmwYVVUAMoyDU8-jUXwaXDPyocgKIREhsx8Y8BfXFniHjP6FSyHb9Exw9RlzjQBnrjsC-NhUaDWinsZC1AEEZX7SCh8V1p_VqNvRHoW_55Ox_4yhlJ3j_BFsbMWyPiiwMrVj84roX6CX4i92D17W_FuDjSy5Tc_K7C1MRpaNsKPsp_FwgkUwg==\" rel=\"nofollow\" target=\"_blank\"><u>Crinetics Pharmaceuticals, Inc.<\/u><\/a> (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.<\/p>\n<p align=\"justify\">\n        <strong>Conference Call &amp; Webcast<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <u>Thursday, February 27 @ 4:30 p.m. ET<\/u>\n      <\/p>\n<p align=\"justify\">Domestic: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-800-267-6316<br \/>International:\u00a0 \u00a0 1-203-518-9783<br \/>Conference ID:\u00a0 CRNXQ4<\/p>\n<p align=\"justify\">\n        <strong>Webcast:<\/strong> Participants can use the dial-in numbers above OR access the live webcast via a direct link (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6yNCRzF0UsBw1rdADFpjCLOVPCMRcGhQwFPjMTbTemDFq70lsy6VJf2IEGiXXrGalbJAJc5cUNa_Ri2h4r8hTJSufqbHoszFNcGE35_JoU6ylBpI7ZQPR9oEeowaRpc2anWYz5Ht09b4c6NoXa6rnQ==\" rel=\"nofollow\" target=\"_blank\">HERE<\/a>) or by visiting the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CBZtGjCi9TBcXlw940H5VVNXslRuksiUHAU7JAFr0x63zCipWdPWVtv7A6Or0Xyg8vktby7Pl2-NrrV7BFONmKjKOr4bnS2zvQhlc9yCP8Z4_yPNsu95vmBlJHExMpDkpKT5A6ecPV-wbb_aBXcI6T729MCJ0fw_HTL_XbwNumf2SvqYylkamDoJD1NnU2-CnkShqfaZ4w2TYKJH-7wdNA==\" rel=\"nofollow\" target=\"_blank\">Events section<\/a> of the Crinetics website. To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled start of the call.<\/p>\n<p align=\"justify\">The webcast will be archived on the Investor Relations section of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K3AHlYhXAMFDUyqQRDYM9JRQRp4daJuTLAXyUuuyrbFM7v0zo_SzNMZYHL3zVA0kuYdZ2LmXTVx5fYSXCZpWrCXAUCXSeDBAolpWTfwZE6E=\" rel=\"nofollow\" target=\"_blank\">www.crinetics.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Crinetics Pharmaceuticals <\/strong><br \/>\n        <br \/>Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Crinetics\u2019 lead development candidate,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-S9oSqeD1ES8714xj89EMxHklvSlE4cUpIpYVa7lJ1KhsBjpAuNhhws2CNCict50O1_1YL91fAyeF5eUpXnyk76KPDaFBlKTvBmufMEJKMSpX3xa95nZURNxnhwI8boOlKQDZHcq2T43SPcJpmOQgRccRbHa8ekzOnVVGWi46nE=\" rel=\"nofollow\" target=\"_blank\">paltusotine<\/a>, is the first investigational once-daily, oral, selective somatostatin receptor type 2 (SST2) nonpeptide agonist that is in clinical development for acromegaly and carcinoid syndrome associated with neuroendocrine tumors. Atumelnant is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing\u2019s syndrome. All of the company\u2019s drug candidates are orally delivered, small molecule, new chemical entities resulting from in-house drug discovery efforts, including additional discovery programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves\u2019 disease (including thyroid eye disease), diabetes, obesity and GPCR-targeted oncology indications.<\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Gayathri Diwakar<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZAwOaJ5-LxCAZd7GBpGJ8B87xk61Ovb-tgPDBaJAmIsFqAT_jdGfoLukr9sZD8z9TvQOjLcfrxNZwhLe2mxLC4MCH354T3EQq-Anl1GRqGw=\" rel=\"nofollow\" target=\"_blank\">gdiwakar@crinetics.com<\/a><br \/>(858) 345-6340<\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Natalie Badillo<br \/>Head of Corporate Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zNEkmc1wW5GeEwtBiUgDmik0o912DdQpbNtRLNclNWqeeH8KUKewBisHGmvaMTZUziEZX3XGKDX2hKNcBTJrHznaZpsnS2nY7C2FaCBxH4M=\" rel=\"nofollow\" target=\"_blank\">nbadillo@crinetics.com<\/a><br \/>(858) 345-6075<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzY0NmY5ZGYtOWQzMC00YTUxLThlZDYtZDM5MzgyN2Q2YTY1LTExMDEzODY=\/tiny\/Crinetics-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference Call &amp; Webcast Thursday, February 27 @ 4:30 p.m. ET Domestic: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-800-267-6316International:\u00a0 \u00a0 1-203-518-9783Conference ID:\u00a0 CRNXQ4 Webcast: Participants can use the dial-in numbers above OR access the live webcast via a direct link (HERE) or by visiting the Events section of the Crinetics website. To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810268","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference Call &amp; Webcast Thursday, February 27 @ 4:30 p.m. ET Domestic: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-800-267-6316International:\u00a0 \u00a0 1-203-518-9783Conference ID:\u00a0 CRNXQ4 Webcast: Participants can use the dial-in numbers above OR access the live webcast via a direct link (HERE) or by visiting the Events section of the Crinetics website. To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled &hellip; Continue reading &quot;Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T22:21:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025\",\"datePublished\":\"2025-02-06T22:21:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/\",\"name\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=\",\"datePublished\":\"2025-02-06T22:21:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","og_locale":"en_US","og_type":"article","og_title":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Market Newsdesk","og_description":"SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference Call &amp; Webcast Thursday, February 27 @ 4:30 p.m. ET Domestic: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-800-267-6316International:\u00a0 \u00a0 1-203-518-9783Conference ID:\u00a0 CRNXQ4 Webcast: Participants can use the dial-in numbers above OR access the live webcast via a direct link (HERE) or by visiting the Events section of the Crinetics website. To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled &hellip; Continue reading \"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-06T22:21:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025","datePublished":"2025-02-06T22:21:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","name":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=","datePublished":"2025-02-06T22:21:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5MSM2NzQwMTg4IzIwODk4MTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810268"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810268\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}